- The document is a transcript of the Q2 and H1 FY2027 Earnings Conference Call held on Monday, November 16, 2026.
- The event was an earnings call to discuss the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
- Management participants included Dr. Manika Khanna (Chairperson and Managing Director), Mr. Rakesh Kumar Sharma (Chief Financial Officer), Mr. Vishad Khanna (Director), and representatives from Adfactors PR (Investor Relations Partners).
- The transcript is available on the company's website at https://www.gaudiumivfcentre.com/investors.
- The company stated that the call contained forward-looking statements and that no unpublished price sensitive information (UPSI) was shared.
Financial Highlights Discussed:
- Q2 FY27 Consolidated Performance: Revenue from operations stood at INR37.4 crores, up 17.9% YoY from INR31.7 crores in Q2 FY26. EBITDA was INR13.5 crores (margin of 36%) compared to INR13.8 crores (43.4% margin) in Q2 FY26. PAT was INR9.4 crores (25.2% margin), flat YoY.
- H1 FY27 Consolidated Performance: Revenue stood at INR56.8 crores, up 14.7% YoY from INR49.5 crores. EBITDA was INR15.9 crores (28% margin) against INR19 crores (38.3% margin). PAT was INR11.2 crores (19.7% margin) compared to INR12.5 crores (25.3% margin).
- Standalone (Core IVF Business) Performance: Q2 revenue grew 22.3% YoY to INR28.1 crores. H1 revenue grew 18.5% YoY to INR41.7 crores.
- Key Metrics: Average Revenue Per Patient (ARPP) for Q2 was ₹3.07 lakhs; for H1 it was ₹3.19 lakhs (up from ₹2.58 lakhs last year). The company completed 889 pickup cycles in Q2. The clinical pregnancy success rate on the first IVF attempt was reported at 62%.
- Expansion Update: Two new hubs were launched in Q2: South Extension, New Delhi (commenced July 16, 2026) and Gurgaon (commenced September 24, 2026). The network now stands at 9 hubs and 38 spokes. Five new locations for future hubs were identified: Lucknow, Calcutta, Guwahati, Surat, and Hyderabad.
- Guidance: The company reaffirmed its FY27 revenue guidance of INR130 crores.
- Balance Sheet: As of September 30, 2026, cash and cash equivalents were INR20.5 crores, with unutilized IPO proceeds of INR39.5 crores. Consolidated debt was INR4.8 crores, resulting in a debt-to-equity ratio of 0.03x. Of the INR90 crores IPO proceeds, INR50.7 crores have been utilized.
Additional Notes Section
- The document is an enclosed transcript submitted as a regulatory filing.
- The transcript contains a full Q&A session with analysts, covering topics like growth aspirations, capacity utilization, receivables, expansion capex, and competitive positioning.
- The company clarified that margin pressure was due to front-loaded expansion costs and increased marketing spend for new hubs, while margins in the existing core business remained stable.
- Receivables stood at INR45.30 crores on a consolidated basis as of September 30, 2026, with days sales outstanding (DSO) of 165 days. The company aims to reduce this to around INR10 crores.
- The company noted that H2 is seasonally stronger, with Q4 typically being the strongest quarter.